Stamford, CT -- (SBWIRE) -- 12/30/2013 -- OTC Stock Picks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Progenics Pharmaceuticals, Inc.(NASDAQ:PGNX), Textura Corp(NYSE:TXTR), Idenix Pharmaceuticals Inc(NASDAQ:IDIX), XOMA Corp(NASDAQ:XOMA)
Progenics Pharmaceuticals, Inc.(NASDAQ:PGNX) was a volume gainer of 1.06 million shares and the average volume of the stock remained 854,477.00 shares. The stock opened the session at $5.71 and finished at the end of the day at $5.36 and the stock plunged -5.80%.The market capitalization of the stock remained 326.02 million. Progenics Pharmaceuticals, Inc. engages in the research and development of biotechnology product candidates in the areas of oncology and therapeutics worldwide. The company offers RELISTOR (methylnaltrexone bromide), a subcutaneous injection for the treatment of opioid induced constipation (OIC) in patients with advanced illnesses.
Has PGNX Found The Bottom And Ready To Gain Momentum? Find Out Here
In the preceding trading session, Textura Corp(NYSE:TXTR) exchanged 3.70 million shares and the average volume remained 669,555.00 shares. The stock closed the session at $29.54 with the drop of -5.62%. Textura Corporation provides on-demand business collaboration software solutions to the commercial construction industry in the United States and Canada. The company?s solutions are focused on facilitating collaboration between owners/developers, general contractors, and subcontractors. Its solutions include Construction Payment Management that facilitates the exchange of invoice documents, supporting documentation.
Why Should Investors Buy TXTR After the Recent Fall? Just Go Here and Find Out
Idenix Pharmaceuticals Inc(NASDAQ:IDIX) decreased -5.48% and its closing price was $6.55. The volume of the stock was 932,172 shares and the average volume remained 959,589.00 shares. The market capitalization of the stock remained 877.70 million. The beta of the stock remained 0.43. Idenix Pharmaceuticals, Inc., a biopharmaceutical company, together with its subsidiaries, engages in the discovery and development of drugs for the treatment of human viral diseases in the United States and France. Its primary research and development focus is on the treatment of patients with hepatitis C virus (HCV). The
Will IDIX Get Buyers Even After The Recent Rally? Find Out Here
XOMA Corp(NASDAQ:XOMA) exchanged its average trading remained 2.30 million shares. XOMA dropped -5.34% and it closed the trading at $6.91. The market capitalization of the stock remained 706.21 million. XOMA Corporation discovers and develops antibody-based therapeutics in the United States, Europe, and the Asia Pacific. The company offers ACEON, an angiotensin converting enzyme inhibitor. Its proprietary products include gevokizumab, a human engineering (HE) antibody to interleukin-1 beta, which is Phase III studies for non-infectious uveitis and Behçets uveitis.
Has XOMA Found The Bottom and Ready To Move Up? Find Out Here
About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.
Read full disclaimer at: http://otcstockpicks.net/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)